Terminalia para Hipoglucemia
Terminalia chebula — 5 estudios científicos revisados
Moderate¿Sirve Terminalia para hipoglucemia?
Debido a sus propiedades antidiabéticas documentadas, el extracto puede reducir los niveles de glucosa en sangre, lo que en combinación con fármacos hipoglucemiantes podría causar una caída excesiva de azúcar.
Compuestos activos involucrados: Alcaloides, Flavonoides, Glucósidos, Saponinas, Taninos, Terpenos, ácido, ácido elágico, Isopreno
Evidencia Científica
Los siguientes estudios han investigado la relación entre Terminalia y hipoglucemia:
Fruits of Terminalia chebula Retz.: A review on traditional uses, bioactive chemical constituents and pharmacological activities.
Fruits of Terminalia chebula Retz. (Combretaceae) are widely used as crude drugs in various traditional medicine systems. The aim of this article is to review the available scientific information regarding the traditional uses, bioactive chemical constituents and the pharmacological activities of T. chebula. Numerous researches conducted on T.
PubMed: 32307775[Pharmacological activity of Terminalia chebula].
Terminalia chebula Retz, known as the "king" of Mongolian and Tibetan medicines, is a drug for a wide range of diseases. The main chemical components of myrobalan include triterpene acid, galloyl glucose, anthraquinonoid. The modern pharmacological studies show that myrobalan has multiple biological activities, including antimicrobial, anti-inflammatory, antioxidation as well as anti-tumor. Based on domestic and foreign literatures in recent years, this paper gave a review on the advance of studies for pharmacological activity of T. chebula.
PubMed: 28871682Potential therapeutic applications for Terminalia chebula in Iranian traditional medicine.
Terminalia chebula (family: Combretaceae) is widely used in the traditional medicine of India and Iran to treat diseases that include dementia, constipation, and diabetes. This tree is known in Iranian traditional medicine (ITM) as halileh or halilaj and the fruit is used to develop treatments. It is described in ITM as an astringent that has a "cold" and "dry" temperament. References to the medicinal properties of Terminalia chebula were collected from important ITM sources and from modern medical databases (PubMed, Scirus, ScienceDirect, and Scopus). The medicinal properties described for th
PubMed: 27400482Terminalia chebula Retz. extract relieves gout arthritis by inhibiting xanthine oxidase, the uric acid transporter, and NLRP3 inflammasome activation.
ETHNOPHARMACOLOGICAL RELEVANCE: Gout is a metabolic disorder accompanied by high serum uric acid levels and joint inflammation due to disturbances in purine metabolism in the body. The dried fruit of Terminalia chebula Retz. is recorded in the "Four Medical Tantras" for the treatment of gout and the core anti-gout component of the Tibetan clinical prescription, such as TongFengTangSan. However, the anti-gout efficacy has not been reported yet. AIM OF STUDY: To evaluate the anti-gout effect and mechanisms of Terminalia chebula Retz.
PubMed: 40268110The development of Terminalia chebula Retz. (Combretaceae) in clinical research.
Medicinal plants are part and parcel of human society to combat diseases from the dawn of civilization. Terminalia chebula Retz. (Fam. Combretaceae), is called the 'King of Medicine' in Tibet and is always listed at the top of the list of 'Ayurvedic Materia Medica' because of its extraordinary power of healing. The whole plant possesses high medicinal value and traditionally used for the treatment of various ailments for human beings.
PubMed: 23620847Seguridad y Precauciones
El uso de Terminalia chebula debe abordarse con extrema cautela debido a su potente actividad biológica. En el caso de mujeres embarazadas y lactantes, no existe evidencia científica suficiente que garantice la seguridad del consumo de este extracto en humanos; por lo tanto, su uso está contraindicado durante el embarazo para evitar riesgos potenciales al desarrollo fetal. En la lactancia, debido a que los compuestos bioactivos como los taninos y ácidos fenólicos pueden pasar a la leche materna, el riesgo de exposición al lactante es incierto, por lo que se recomienda evitar su administración para prevenir efectos sistémicos no controlados en el bebé. Para niños menores de 12 años, la seguridad de la Terminalia chebula no ha sido establecida. Debido a que los procesos metabólicos y la madurez de los órganos (especialmente el hígado y los riñones) en la infancia son distintos a los de los adultos, el uso de dosis terapéuticas podría resultar en toxicidad o alteraciones en el desarrollo. No se recomienda su uso en esta población sin supervisión médica estricta.
Otras plantas estudiadas para Hipoglucemia
Perfil completo: Ver todos los usos y evidencia de Terminalia →